Journal article
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Cell (Cambridge), Vol.182(3), pp.744-753.e4
08/06/2020
DOI: 10.1016/j.cell.2020.06.011
PMID: 32553273
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic with millions of human infections. One limitation to the evaluation of potential therapies and vaccines to inhibit SARS-CoV-2 infection and ameliorate disease is the lack of susceptible small animals in large numbers. Commercially available laboratory strains of mice are not readily infected by SARS-CoV-2 because of species-specific differences in their angiotensin-converting enzyme 2 (ACE2) receptors. Here, we transduced replication-defective adenoviruses encoding human ACE2 via intranasal administration into BALB/c mice and established receptor expression in lung tissues. hACE2-transduced mice were productively infected with SARS-CoV-2, and this resulted in high viral titers in the lung, lung pathology, and weight loss. Passive transfer of a neutralizing monoclonal antibody reduced viral burden in the lung and mitigated inflammation and weight loss. The development of an accessible mouse model of SARS-CoV-2 infection and pathogenesis will expedite the testing and deployment of therapeutics and vaccines.
[Display omitted]
•Adenovirus transduction of human ACE2 enables SARS-CoV-2 infection of BALB/c mice•High levels of viral RNA and infectious SARS-CoV-2 accumulate in lungs•Mice transduced with human ACE2 develop viral pneumonia after SARS-CoV-2 infection•Neutralizing mAbs protect from SARS-CoV-2-induced lung infection and inflammation
Laboratory mice transduced with adenoviruses encoding human ACE2 are permissive for SARS-CoV-2 and develop pneumonia. Passive transfer of a neutralizing monoclonal antibody reduces lung infection, inflammation, and disease.
Details
- Title: Subtitle
- A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
- Creators
- Ahmed O Hassan - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USAJames Brett Case - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USAEmma S Winkler - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USALarissa B Thackray - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USANatasha M Kafai - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USAAdam L Bailey - Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USABroc T McCune - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USAJulie M Fox - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USARita E Chen - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USAWafaa B Alsoussi - Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USAJackson S Turner - Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USAAaron J Schmitz - Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USATingting Lei - Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USASwathi Shrihari - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USAShamus P Keeler - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USADaved H Fremont - Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USASuellen Greco - Department of Comparative Medicine, Washington University School of Medicine, St. Louis, MO 63110, USAPaul B McCray - Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USAStanley Perlman - Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USAMichael J Holtzman - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USAAli H Ellebedy - Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USAMichael S Diamond - Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
- Resource Type
- Journal article
- Publication Details
- Cell (Cambridge), Vol.182(3), pp.744-753.e4
- Publisher
- Elsevier Inc
- DOI
- 10.1016/j.cell.2020.06.011
- PMID
- 32553273
- ISSN
- 0092-8674
- eISSN
- 1097-4172
- Grant note
- DOI: 10.13039/100000002, name: National Institutes of Health; DOI: 10.13039/100000185, name: Defense Advanced Research Projects Agency
- Language
- English
- Date published
- 08/06/2020
- Academic Unit
- Microbiology and Immunology; Pulmonary Medicine; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Infectious Disease (Pediatrics); Internal Medicine
- Record Identifier
- 9984070872402771
Metrics
35 Record Views